[1]
“Efficacy, Safety and Tolerability Of Valsartan Plus HCTZ in Patients With Essential Hypertension: A Multicentre Observational Study in Bangladesh”, Cardiovasc. j., vol. 3, no. 1, pp. 37–44, Nov. 2010, doi: 10.3329/cardio.v3i1.6425.